There is research on this stock available only to PRO subscribers.
We currently have no Breaking News on this stock.
IMMU vs. ETF Alternatives
Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
Other News & PR